Text Size
19 studies found for:    Pulmonary Embolism | Open Studies | NIH, U.S. Fed

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Assessing the Prognosis of Pulmonary Embolism Using Clinical and Imaging Biomarkers (Retrospective & Prospective )
Condition: Pulmonary Embolism
Intervention:
2 Recruiting Assessment of Acute Disease to Reduce Imaging Costs
Conditions: Acute Coronary Syndrome;   Pulmonary Embolism
Interventions: Device: Pilot Phase;   Device: Intervention group, receive the numeric PTP estimate;   Device: No Intervention
3 Unknown † Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing
Conditions: Atrial Fibrillation;   Deep Venous Thrombosis;   Heart Valve Replacement;   Pulmonary Embolism
Intervention: Drug: Coumadin
4 Recruiting A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Conditions: Venous Thromboembolism;   Pulmonary Embolism
Intervention: Drug: dalteparin injection
5 Recruiting Development of Computer-aided Detection and Diagnosis From Imaging Techniques
Condition: Diagnostic Imaging
Intervention:
6 Recruiting The Spot Sign for Predicting and Treating ICH Growth Study
Condition: Intracerebral Hemorrhage
Interventions: Drug: recombinant activated factor VII;   Drug: placebo
7 Recruiting Pharmacogenetics of Warfarin in Puerto Rican Patients Using a Physiogenomics Approach
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Antiphospholipid Syndrome;   Coagulopathy
Intervention:
8 Recruiting Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
Conditions: Cardiovascular Disease;   HIV Infections
Intervention:
9 Recruiting Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)
Conditions: Arterial Thromboembolic Events;   Atrial Fibrillation
Interventions: Drug: Placebo;   Drug: Dalteparin
10 Recruiting Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Conditions: Deep Vein Thrombosis;   Venous Thrombosis;   Postphlebitic Syndrome;   Venous Thromboembolism;   Post Thrombotic Syndrome
Intervention: Drug: Recombinant tissue plasminogen activator (rt-PA)
11 Recruiting Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: rosuvastatin
12 Recruiting Red Cell Storage Duration Study
Conditions: Cardiac Surgery;   Erythrocyte Transfusion
Interventions: Biological: Red blood cell units stored <= 10 days;   Biological: Red blood cell units stored >= 21 days
13 Recruiting Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: orteronel;   Drug: triptorelin
14 Unknown † Clinical and Economic Implications of Genetic Testing for Warfarin Management
Condition: Blood Coagulation Disorders
Intervention: Drug: Warfarin
15 Recruiting Operative Strategies to Reduce Cerebral Embolic Events During Coronary Artery Bypass Surgery
Condition: Stroke
Interventions: Procedure: No aortic clamping;   Procedure: partial occluding clamp;   Procedure: single cross clamp;   Procedure: cross clamp and partial occluding clamp
16 Unknown † The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A
Conditions: Hypercholesterolemia;   Thrombosis
Interventions: Drug: Clopidogrel;   Drug: Atorvastatin
17 Recruiting Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT
Condition: Thromboembolism
Interventions: Other: Pharmacogenetic Warfarin Initiation;   Other: Clinical Warfarin Initiation (non-pharmacogenetic)
18 Recruiting Predictors of Anticoagulation Control on Warfarin Therapy
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Heart Valve Replacement
Intervention:
19 Recruiting Evaluation of the Duration of Therapy for Thrombosis in Children
Condition: Venous Thrombosis
Interventions: Other: Shortened duration (6 weeks) of anticoagulant therapy;   Other: Conventional duration (3 months) of anticoagulant therapy;   Other: No Intervention;   Drug: Dalteparin
To Top

† Indicates status has not been verified in more than two years